VOLITIONRX LTD Logo

VOLITIONRX LTD

Develops epigenetic blood tests for early cancer and sepsis detection in human/veterinary markets.

VNRX | US

Overview

Corporate Details

ISIN(s):
US9286611077
LEI:
Country:
United States of America
Address:
1489 WEST WARM SPRINGS ROAD, 89014 HENDERSON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

VolitionRx Ltd. is a multi-national epigenetics company that develops and commercializes blood-based diagnostic tests for the early detection and monitoring of life-altering diseases. The company's core technology is its proprietary Nu.Q® platform, a nucleosome quantification technology that detects epigenetic biomarkers in circulating chromatin. This platform enables the creation of simple, cost-effective, and non-invasive assays. Volition's primary applications are in oncology and sepsis for both the human and veterinary markets. The company's goal is to improve outcomes by enabling earlier diagnosis, monitoring disease progression, and evaluating treatment responses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VOLITIONRX LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VOLITIONRX LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VOLITIONRX LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DONGWHA PHARM.CO.,LTD Logo
Develops, manufactures, and sells a diverse portfolio of healthcare products globally.
South Korea
000020
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland
DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden
DBP B
DR REDDYS LABORATORIES LTD Logo
Global pharma firm providing affordable generics, APIs, and medicines to patients worldwide.
United States of America
RDY
Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.
South Korea
176750
Dx & Vx Co., Ltd. Logo
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
South Korea
180400
DYNAVAX TECHNOLOGIES CORP Logo
Biopharma firm developing novel vaccines, like its adult hepatitis B vaccine, with adjuvant tech.
United States of America
DVAX
Dyne Therapeutics, Inc. Logo
Developing targeted therapies for genetic neuromuscular diseases via its FORCE™ platform.
United States of America
DYN
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea
044960
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom
EAH

Talk to a Data Expert

Have a question? We'll get back to you promptly.